Third Amendment to Lease by and between Bullfinch Square Limited Partnership and Leap Therapeutics, Inc., dated as of May 16, 2022
Exhibit 10.1
THIRD AMENDMENT TO LEASE
This is a Third Amendment to Lease dated as of May 16, 2022 by and between Bulfinch Square Limited Partnership, a Massachusetts limited partnership (“Landlord”) and Leap Therapeutics, Inc., a Delaware corporation (“Tenant”).
WHEREAS, Landlord and Tenant entered into a Lease dated November 13, 2018, as amended by First Amendment to Lease dated August 17, 2021 and Second Amendment to Lease dated as of October 1, 2021 (as so amended, the “Lease”) with respect to certain premises at 47 Thorndike Street, Cambridge, Massachusetts; and
WHEREAS, Tenant wishes to extend the term of the Lease until July 31, 2024 from its current expiration of January 31, 2023; and
NOW, THEREFORE, in consideration of the foregoing, Landlord and Tenant agree as follows:
-2-
IN WITNESS WHEREOF, Landlord and Tenant have executed this Third Amendment to Lease as of the date first set forth above.
| LANDLORD: | ||
| | ||
| Bulfinch Square Limited Partnership | ||
| | ||
| By: | Courthouse Associates, Inc., its general partner | |
| | | |
| | By: | /s/ Kenneth Krozy |
| | | Kenneth Krozy |
| | | Vice President |
| TENANT: | ||
| | ||
| Leap Therapeutics, Inc. | ||
| | ||
| By: | /s/ Douglas E. Onsi | |
| | Name: | Douglas E. Onsi |
| | Title: | President & CEO |